Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
60.13
+1.97 (3.39%)
Nov 4, 2024, 4:00 PM EST - Market closed

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Net Income
-85.3-81.17-58.03-21.96
Depreciation & Amortization
3.353.632.511.6
Loss (Gain) From Sale of Assets
0.070.07-0.01
Loss (Gain) From Sale of Investments
-0.17-0.08-0.150.02
Stock-Based Compensation
3.462.381.140.81
Other Operating Activities
4.613.611.51-13.47
Change in Accounts Payable
2.253.11.760.06
Change in Unearned Revenue
----0.69
Change in Other Net Operating Assets
2.381.18-2.391.53
Operating Cash Flow
-69.36-67.28-53.65-32.09
Capital Expenditures
-13.47-7.84-5.21-4.45
Sale of Property, Plant & Equipment
---0.01
Investment in Securities
-95.431916.27-35.07
Investing Cash Flow
-108.9111.1611.06-39.5
Issuance of Common Stock
154.73154.550.060.03
Other Financing Activities
-12.02-12.25-0.04-0.03
Financing Cash Flow
210.09187.760.02115.95
Net Cash Flow
31.82131.64-42.5744.35
Free Cash Flow
-82.84-75.12-58.86-36.54
Free Cash Flow Per Share
-14.68-49.12-230.65-8.22
Cash Income Tax Paid
0.050.030.01-
Levered Free Cash Flow
-62.7-47.69-38.2-
Unlevered Free Cash Flow
-62.7-47.69-38.2-
Change in Net Working Capital
-1.22-6.97-0.24-
Source: S&P Capital IQ. Standard template. Financial Sources.